172 related articles for article (PubMed ID: 37463582)
1. Circulating T cell profiles associate with enterotype signatures underlying hematological malignancy relapses.
Vallet N; Salmona M; Malet-Villemagne J; Bredel M; Bondeelle L; Tournier S; Mercier-Delarue S; Cassonnet S; Ingram B; Peffault de Latour R; Bergeron A; Socié G; Le Goff J; Lepage P; Michonneau D
Cell Host Microbe; 2023 Aug; 31(8):1386-1403.e6. PubMed ID: 37463582
[TBL] [Abstract][Full Text] [Related]
2. Effect of Azithromycin on Airflow Decline-Free Survival After Allogeneic Hematopoietic Stem Cell Transplant: The ALLOZITHRO Randomized Clinical Trial.
Bergeron A; Chevret S; Granata A; Chevallier P; Vincent L; Huynh A; Tabrizi R; Labussiere-Wallet H; Bernard M; Chantepie S; Bay JO; Thiebaut-Bertrand A; Thepot S; Contentin N; Fornecker LM; Maillard N; Risso K; Berceanu A; Blaise D; Peffault de La Tour R; Chien JW; Coiteux V; Socié G;
JAMA; 2017 Aug; 318(6):557-566. PubMed ID: 28787506
[TBL] [Abstract][Full Text] [Related]
3. Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation.
Vallet N; Le Grand S; Bondeelle L; Hoareau B; Corneau A; Bouteiller D; Tournier S; Derivry L; Bohineust A; Tourret M; Gibert D; Mayeur E; Itzykson R; Pacchiardi K; Ingram B; Cassonnet S; Lepage P; Peffault de Latour R; Socié G; Bergeron A; Michonneau D
Blood; 2022 Dec; 140(23):2500-2513. PubMed ID: 35984904
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors of second hematopoietic allogeneic stem cell transplantation among hematological malignancy patients relapsed after first hematopoietic stem cell transplantation: A single center study.
Lu Y; Zhang JP; Zhao YL; Xiong M; Sun RJ; Cao XY; Wei ZJ; Zhou JR; Liu DY; Yang JF; Zhang X; Lu DP; Lu P
Front Immunol; 2022; 13():1066748. PubMed ID: 36685540
[TBL] [Abstract][Full Text] [Related]
5. TNFR2 blockade of regulatory T cells unleashes an antitumor immune response after hematopoietic stem-cell transplantation.
Moatti A; Debesset A; Pilon C; Beldi-Ferchiou A; Leclerc M; Redjoul R; Charlotte F; To NH; Bak A; Belkacemi Y; Salomon BL; Issa F; Michonneau D; Maury S; Cohen JL; Thiolat A
J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35387779
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies: A Single-center Study].
Lu JP; Wen SP; Wang FX; Li SH; Niu ZY; Wang Y; Zhou ZW; Xu Z; Wang ZZ; Zhang XJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Aug; 30(4):1238-1243. PubMed ID: 35981391
[TBL] [Abstract][Full Text] [Related]
7. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
8. Comparison of clinical outcomes between unrelated single umbilical cord blood and "ex-vivo" T-cell depleted haploidentical transplantation in children with hematological malignancies.
Gómez-Santos C; González-Vicent M; Molina B; Deltoro N; Herrero B; Ruiz J; Pérez-Martínez A; Diaz MA
World J Pediatr; 2021 Dec; 17(6):609-618. PubMed ID: 34590210
[TBL] [Abstract][Full Text] [Related]
9. Azithromycin does not increase hematologic relapse in pediatric hematopoietic cell transplant recipients.
Sabulski A; Wallace G; Lane A; Davies SM; Myers KC
Bone Marrow Transplant; 2022 Oct; 57(10):1589-1591. PubMed ID: 35778608
[No Abstract] [Full Text] [Related]
10. Azithromycin Use and Increased Cancer Risk among Patients with Bronchiolitis Obliterans after Hematopoietic Cell Transplantation.
Cheng GS; Bondeelle L; Gooley T; He Q; Jamani K; Krakow EF; Flowers MED; de Latour RP; Michonneau D; Socié G; Chien JW; Chevret S; Bergeron A
Biol Blood Marrow Transplant; 2020 Feb; 26(2):392-400. PubMed ID: 31682980
[TBL] [Abstract][Full Text] [Related]
11. Association of Gut Microbiota Enterotypes with Blood Trace Elements in Women with Infertility.
Yao X; Zuo N; Guan W; Fu L; Jiang S; Jiao J; Wang X
Nutrients; 2022 Aug; 14(15):. PubMed ID: 35956371
[TBL] [Abstract][Full Text] [Related]
12. Enterotype May Drive the Dietary-Associated Cardiometabolic Risk Factors.
de Moraes AC; Fernandes GR; da Silva IT; Almeida-Pititto B; Gomes EP; Pereira AD; Ferreira SR
Front Cell Infect Microbiol; 2017; 7():47. PubMed ID: 28280715
[TBL] [Abstract][Full Text] [Related]
13. Ex vivo T-cell-depleted allogeneic stem cell transplantation for hematologic malignancies: The search for an optimum transplant T-cell dose and T-cell add-back strategy.
Anandi P; Tian X; Ito S; Muranski P; Chokshi PD; Watters N; Chawla U; Hensel N; Stroncek DF; Battiwalla M; Barrett AJ
Cytotherapy; 2017 Jun; 19(6):735-743. PubMed ID: 28395942
[TBL] [Abstract][Full Text] [Related]
14. Characterizing Enterotypes in Human Metagenomics: A Viral Perspective.
Song L; Zhang L; Fang X
Front Microbiol; 2021; 12():740990. PubMed ID: 34659174
[TBL] [Abstract][Full Text] [Related]
15. Gut enterotypes are stable during Bifidobacterium and Lactobacillus probiotic supplementation.
Haddad EN; Sugino KY; Tucker RM; Comstock SS
J Food Sci; 2020 May; 85(5):1596-1604. PubMed ID: 32267970
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the Gut Microbiota in Urban Thai Individuals Reveals Enterotype-Specific Signature.
Sinsuebchuea J; Paenkaew P; Wutthiin M; Nantanaranon T; Laeman K; Kittichotirat W; Wattanachaisaereekul S; Dulsawat S; Nopharatana M; Vorapreeda N; Bhumiratana S; Cheevadhanarak S; Sutheeworapong S
Microorganisms; 2023 Jan; 11(1):. PubMed ID: 36677429
[TBL] [Abstract][Full Text] [Related]
17. Microbial enterotypes in personalized nutrition and obesity management.
Christensen L; Roager HM; Astrup A; Hjorth MF
Am J Clin Nutr; 2018 Oct; 108(4):645-651. PubMed ID: 30239555
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic hematopoietic stem cell transplantation in patients with therapy-related hematologic malignancies developing after multiple myeloma.
Vasudevan Nampoothiri R; Pasic I; Law AD; Lam W; Chen C; Michelis FV; Kim DDH; Gerbitz A; Lipton JH; Kumar R; Mattsson J; Viswabandya A
Eur J Haematol; 2022 May; 108(5):430-436. PubMed ID: 35100661
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic CD19-CAR-T cell infusion after allogeneic hematopoietic stem cell transplantation in B cell malignancies.
Liu J; Zhong JF; Zhang X; Zhang C
J Hematol Oncol; 2017 Jan; 10(1):35. PubMed ID: 28143567
[TBL] [Abstract][Full Text] [Related]
20. "Ex-vivo" T-cell depletion in allogeneic hematopoietic stem cell transplantation: New clinical approaches for old challenges.
Diaz MA; Gasior M; Molina B; Pérez-Martínez A; González-Vicent M
Eur J Haematol; 2021 Jul; 107(1):38-47. PubMed ID: 33899960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
